DOCSLIB.ORG

The Pharmacologist Vol. 54

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pharmacologist Vol. 54 Vol. 54 Number 3 2012 The Pharmacologist September ASPET Annual Mee ng at Experimental Biology 2013 Joint mee ng with the Bri sh Pharmacological Society; guest socie es include the Canadian Society for Pharmacology and Therapeu cs & the Behavioral Pharmacology Society Saturday, April 20 - Wednesday, April 24 Skyline from Boston Harbor Paul Revere Statue Fenway Park In this issue: Message from new ASPET President, John Lazo Informa on for ASPET Annual Mee ng at EB 2013 ASPET Membership Survey Results New ASPET Commi ee & Division Lists Congress Returns, Mulls NIH Funding MAPS Annual Mee ng Program Informa on Great Lakes Chapter Mee ng Abstracts Customs House Bunker Hill Monument The Pharmacologist 137 Volume 54 Number 3, 2012 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Contents Therapeu cs. Message from the President 139 EDITOR Gary Axelrod EDITORIAL ADVISORY BOARD ASPET Annual Mee ng at EB 2013 Stephen M. Lanier, PhD Charles P. France, PhD Important Dates 141 Kenneth E. Thummel, PhD COUNCIL Preliminary Program 141 President John S. Lazo, PhD Annual Mee ng News 153 President-Elect Richard R. Neubig, MD, PhD 4th GPCR Colloquium: April 24 - 25, 2013 154 Past President Lynn Wecker, PhD 2012 Annual Membership Survey Results 156 Secretary/Treasurer Edward T. Morgan, PhD New ASPET Commi ee Lists 158 Secretary/Treasurer-Elect Sandra P. Welch, PhD ASPET Commi ee Reorganiza on 160 Past Secretary/Treasurer Mary E. Vore, PhD Journals 162 Councilors Charles P. France, PhD Science Policy 164 Stephen M. Lanier, PhD Kenneth E. Thummel, PhD Chair, Board of Publica ons Trustees Integra ve and Organ System Sciences 166 James E. Barre , PhD Chair, Program Commi ee Social Media 167 Sco Waldman, MD, PhD FASEB Board Representa ve Members in the News 171 Brian M. Cox, PhD Execu ve Offi cer Staff News 172 Chris ne K. Carrico, PhD The Pharmacologist (ISSN 0031-7004) is published quarterly in New ASPET Members 173 March, June, September, and December by the American Society for Pharmacology and Experimental Therapeu cs, 9650 Rockville In Sympathy 175 Pike, Bethesda, MD 20814-3995. Annual subscip on rates: $20.00 for ASPET members; $45.00 for U.S. nonmembers and ins tu ons; $70.00 for nonmembers and ins tu ons outside Obituary: Avram Goldstein 175 the U.S. Single copy: $20.00. Copyright © 2012 by the American Society for Pharmacology and Experimental Therapeu cs Inc. All Division News, Including New ASPET Division Lists 177 rights reserved. Periodicals postage paid at Bethesda, MD. GST number for Canadian subscribers: BN:13489 2330 RT. Chapter News ASPET assumes no responsibility for the statements and opinions advanced by contributors to The Pharmacologist. Mid-Atlan c 184Deadlines for submission of material for publica on: Issue 1, February 15; Issue 2, May 16; Issue 3, August 15; and Issue 4, November 15. Great Lakes 184 Postmaster: Send address changes to: The Pharmacologist, ASPET, 9650 Rockville Pike, Bethesda, MD 20814-3995. Membership Informa on 199 Membership Applica on 200 2013 Dues No ces Please check your email inbox for your 2013 Dues no ce. You can mail your payment or renew online at h ps://www.aspet.org/login.aspx, no later than January 1, 2013. The Pharmacologist 138 Volume 54 Number 3, 2012 Message from the President Dear ASPET Members, It is a great honor to serve as the 81st President of ASPET, and I would like to thank everyone who helped in my elec on. I sincerely hope to fulfi ll expecta ons of all of ASPET’s members and trust you will communicate your thoughts and needs throughout the next year. This is a truly dynamic me for pharmacology and experimental therapeu cs. The confl uence of rapidly grow- ing genomic and proteomic databases, disease-associated molecular drug targets, high throughput screening programs, small molecule libraries, sophis cated computa onal tools for drug target docking, computer assisted drug design, nanotechnology-inspired delivery systems, advance microscopy tools including intravital imaging, and gene cally modifi ed animal models has s mulated a broad increase in the strategies to produce and test new poten al therapeu cs. The success of an body-based therapies including an body-drug conjugates adds new dimensions to the ASPET interests. When construc ng an elec on pla orm, I emphasized the need for ASPET to expand its membership and embrace individuals who iden fy with these emerging areas. Recognizing that expanding any self-associa ng professional community requires me, the goal of my administra on will be to infuse a spirit of inclusiveness. I have already begun to work with Rick Neubig, ASPET’s President-Elect, to ensure there is a con nuum of this eff ort for the next two years. As part of this eff ort, we plan to co-sponsor a Symposium at Experimental Biology 2013 en tled “Systems Biology Answering Pharmacological Ques ons.” It should be a great program, so I urge you to please try to a end it. One of the main topics at our Council Retreat last October focused on how we can enhance our ability to a ract new members. You should see some evidence of how we plan to opera onalize these discussions in the coming year. The dynamic events are not simply in the science of pharmacology. We face serious challenges in the areas of educa on, scien fi c publica- on, and research funding. Our Past President, Lynn Wecker, emphasized the need to provide junior level inves gators the resources and mentoring to ensure their future success. This must con nue par cularly in this period of fi scal restric on and educa onal reform. The use of electronic and social media and online learning are clearly reshaping the future of how we interact and communicate. The ASPET website has improved drama cally under Lynn’s and Chris e Carrico’s careful leadership, and we have a presence on Facebook, Twi er, and LinkedIn. If you have not visited these sites, I encourage you to do so as they are very informa ve. ASPET’s Educa on Division, under the leadership of Lynn Crespo, provided a fabulous session at our last annual mee ng, and I look forward to addi onal contribu ons from this group. ASPET also should focus some a en on on ensuring predoctoral funding remains vibrant for our fi eld, which is highly important for the economy of our na ons. We must also recognize the needs for postgraduate educa on of our members who are in private and governmental sectors. It is par cularly important that we stay at the forefront of the changes in the teaching of pharmacology at medical schools, which refl ect ini a ves by the USMLE and LCME. It is almost impossible to ignore the changes that are occurring in scien fi c publica ons. ASPET is righ ully proud of its long tradi on in publishing superior peer-reviewed journals. Our journals provide members and others an eff ec ve and economical vehicle to present their research fi ndings to the world. We must ensure they con nue to fulfi ll that mission in an era of increased compe on, open access, and online publica on. The last several years have been very diffi cult for individuals seeking NIH grants with funding rates at historical lows. Young members peer out into the future and fear it will be almost impossible to establish an independent laboratory; more senior members worry about not being funded in the future even with worthy proposals. As a member of FASEB, we have been vocal in our call for con nued support for NIH funding. Jim Bernstein has been vigilant in providing our members with informa on about the future of funding. As President, I will endeavor to provide the public and our representa ves with the factual informa on about the importance of our research. We are a na onal treasure that provides great value to the health and welfare of our society. The current challenges provide ASPET an unusual opportunity to experiment with new approaches to meet the needs of our membership. I welcome your thoughts at any me and an cipate your engagement in this great adventure. Sincerely, John S. Lazo, Ph.D. The Pharmacologist 139 Volume 54 Number 3, 2012 Participate in the ASPET Member-Get-A-Member Program Get one Apple iPad Regular, Post-doc, or Affi liate (paying) member) to join Boston Meeting ASPET and ASPET T-Shirt Registration get a FREE ASPET T-shirt! Get any member (including Students)) to join ASPET and bee entered into a raffl e to Get Started Today! win an Apple iPad or Free Meeting - Tell a friend, colleague or student about the benefi ts of membership Registration! -Encourage them to fi ll out an application form online at: www.aspet.org The more -Tell them to enter Marketing Code: MGM and people you provide your name as their sponsor recruit, the more -Once they are approved for new membership and their dues payment has been made, you will receive credit chances you have to for your recruitment efforts win a grand prize! -If you have any questions about this program, (Apple iPad or please contact the membership Meeting department at [email protected] Registration) or call (301) 634-7060 By helping us recruit new members, you will be contributing to the growth and sustainability of ASPET. A growing ASPET means great recognition for the fi eld of pharmacology, more resources and support for our members, and a louder voice with policy makers. For more program details, visit: http://www.aspet.org/membership/member-get-a-member/ The Pharmacologist 140 Volume 54 Number 3, 2012 Annual Meeting Joint meeting with the British Pharmacological Society; guest societies include the Canadian Society for Pharmacology and Therapeutics & the Behavioral Pharmacology Society Saturday, April 20 - Wednesday, April 24 Boston, MA Important Dates to Remember Abstract Submission Deadline: Thursday, November 8, 2012 Early Registra on Deadline: February 22, 2013 Deadline for Discounted Hotel Reserva ons: March 22, 2013 Registra on is now open.
Load more

Recommended publications
  • A Matter of Degree We Ask Experts What Steers So Many Black Scientists Toward Earning a Master’S Before a Ph.D
    Vol. 19 / No. 2 / February 2020 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY A matter of degree We ask experts what steers so many black scientists toward earning a master’s before a Ph.D. Don’t wait a lifetime for a decision. C. elegans daf-2 mutants can live up to 40 days. JBC takes only 17 days on average to reach a fi rst decision about your paper. Learn more about fast, rigorous review at jbc.org. www.jbc.org NEWS FEATURES PERSPECTIVES 2 24 52 EDITOR’S NOTE A MATTER OF DEGREE A BEGINNER’S GUIDE TO MINORITY Picking up the slack What steers so many black scientists toward PROFESSOR HIRES 3 earning a master’s before a Ph.D.? NEWS FROM THE HILL 34 Acting to protect research integrity MEYERHOFF SCHOLARS A model for increasing diversity in STEM ANNUAL 4 MEETING MEMBER UPDATE 36 INCLUSIVE EXCELLENCE 7 36 A goal of lasting change NEWS 39 Program at Northeastern aims to fix the Honoring undergrads who promote diversity institution 8 40 RETROSPECTIVE FOR VULNERABLE POPULATIONS, Kensal E. van Holde (1928 – 2019) THE THORNY ETHICS OF GENETIC DATA COLLECTION 10 44 RESEARCH SPOTLIGHT JBC/TABOR AWARDS Understanding how arsenic changes 44 chromatin and causes cancer Award winners to speak at annual 13 24 meeting 45 NEWS Lavrsen finds endless possibilities Don’t wait a lifetime for a decision. Nan-Shan Chang has made WWOX in PTMs his life’s work 46 Varghese roams from forests to C. elegans daf-2 mutants can live up to 40 days.
    [Show full text]
  • Medical Center
    VanderbiltUniversityMedicalCenter Medical Center School of Medicine School of Nursing Hospital and Clinic Vanderbilt University 2002/2003 Containing general information and courses of study for the 2002/2003 session corrected to 1 July 2002 Nashville The University reserves the right, through its established procedures, to modify the require- ments for admission and graduation and to change other rules, regulations, and provisions, including those stated in this bulletin and other publications, and to refuse admission to any student, or to require the withdrawal of a student if it is determined to be in the interest of the student or the University. All students, full- or part-time, who are enrolled in Vanderbilt courses are subject to the same policies. Policies concerning non-curricular matters and concerning withdrawal for medical or emo- tional reasons can be found in the Student Handbook. EQUAL OPPORTUNITY In compliance with federal law, including the provisions of Title IX of the Education Amend- ments of 1972, Sections 503 and 504 of the Rehabilitation Act of 1973, and the Americans with Disabilities Act of 1990, Vanderbilt University does not discriminate on the basis of race, sex, religion, color, national or ethnic origin, age, disability, or military service in its administration of educational policies, programs, or activities; its admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. In addition, the University does not discriminate on the basis of sexual orien- tation consistent with University non-discrimination policy. Inquiries or complaints should be directed to the Opportunity Development Officer, Baker Building, VU Station B #351809 Nashville, Tennessee 37235-1809.
    [Show full text]
  • The Member Magazine of the American Society for Biochemistry and Molecular Biology
    Vol. 14 / No. 3 / March 2015 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY CONTENTS NEWS FEATURES PERSPECTIVES 2 14 50 PRESIDENT’S MESSAGE GIVING PARASITES THEIR DUE COORDINATES Conscience of commitment Chasing the North American Dream 20 4 STEAM 52 NEWS FROM THE HILL When our DNA is fair game CAREER INSIGHTS Gene-editing summit A Q&A with Clemencia Rojas 22 5 ANNUAL MEETING POINTERS 14 MEMBER UPDATE 32 8 ANNUAL AWARDS RETROSPECTIVE Marion Sewer (1972 – 2016) 22 10 JOURNAL NEWS 10 Turning on the thyroid 20 11 Using microRNAs to target cancer cells 12 A mouse model for Hajdu–Cheney syndrome 13 One gene, two proteins, one complex 8 32 50 2016 10 Annual Aards MARCH 2016 ASBMB TODAY 1 PRESIDENT’S MESSAGE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY Conscience OFFICERS COUNCIL MEMBERS Steven McKnight Squire J. Booker of commitment President Karen G. Fleming Gregory Gatto Jr. Natalie Ahn Rachel Green By Steven McKnight President-Elect Susan Marqusee Karen Allen Jared Rutter Secretary Brenda Schulman Michael Summers very four years, my institution work with the American Society for Toni Antalis Treasurer requires that I take a course Biochemistry and Molecular Biol- ASBMB TODAY EDITORIAL ADVISORY BOARD E and exam regarding conicts ogy, I can help organize and attend EX-OFFICIO MEMBERS Charles Brenner of interest. Past courses have focused meetings, I can give lectures at other Squire Booker Chair primarily on nancial conicts of institutions, I can help found biotech- Wei Yang Michael Bradley Co-chairs, 2016 Annual Floyd “Ski” Chilton interest, but the course and test I took nology companies, and on and on — Meeting Program Cristy Gelling this past month had a new category so long as the activities have legitimate Committee Peter J.
    [Show full text]
  • Chromatin, SF-1, and Ctbp Structural and Post-Translational Modifications Induced by ACTH/Camp Accelerate CYP17 Transcription Rate
    Chromatin, SF-1, and CtBP Structural and Post-Translational Modifications Induced by ACTH/cAMP Accelerate CYP17 Transcription Rate A Dissertation Presented to The Academic Faculty By Eric B. Dammer In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Applied Biology Georgia Institute of Technology December 2008 Chromatin, SF-1, and CtBP Structural and Post-Translational Modifications Induced by ACTH/cAMP Accelerate CYP17 Transcription Rate Approved by: Dr. Marion B. Sewer, Advisor School of Biology Georgia Institute of Technology Dr. Kirill S. Lobachev Dr. Donald F. Doyle School of Biology School of Chemistry and Biochemistry Georgia Institute of Technology Georgia Institute of Technology Dr. Alfred H. Merrill, Jr. Dr. Edward T. Morgan School of Biology Department of Pharmacology Georgia Institute of Technology Emory University History is merely a list of surprises. It can only prepare us to be surprised yet again. -Kurt Vonnegut For Kate and Jeran, and Dad- ACKNOWLEDGEMENTS This work would not have been possible without the support and mentoring of my advisor, Dr. Marion Sewer. The amount of trust she extends and effort she expends on behalf of each of her students makes a tremendous difference not only in the life of each of us, but also in the lives we each have been enabled to touch through our continued efforts after our paths go separate ways. The environment in which scientific exchange occurs has been indispensible for my work to proceed; in particular, I am grateful for the collegial atmosphere of sharing and constructive interaction with fellow lab members, including Aarti Urs, Tuba Ozbay, Adam Leon, Anne Rowan, Dr.
    [Show full text]
  • PDF Document
    Acta Chim. Slov. 2008, 55, 53–57 53 Mini review Multiple Signaling Pathways Coordinate CYP17 Gene Expression in the Human Adrenal Cortex Marion B. Sewer*, Donghui Li, Eric B. Dammer, Srinath Jagarlapudi and Natasha Lucki School of Biology and Parker H. Petit Institute for Bioengineering & Biosciences, Georgia Institute of Technology, Atlanta, GA 30332-0230 * Corresponding author: [email protected] Received: 17-09-2007 Abstract Optimal levels of steroid hormone biosynthesis are assured by the integration of several regulatory mechanisms, includ- ing substrate delivery, enzymatic activity, and gene transcription. In the human adrenal cortex, optimal glucocorticoid secretion is achieved by the actions of adrenocorticotropin (ACTH), which exerts transcriptional pressure on all genes involved in steroidogenesis. One of these genes is CYP17, which encodes P450 17α-hydroxylase-17,20 lyase, a key en- zyme in the production of cortisol and adrenal androgens. Levels of CYP17 transcription are regulated by multiple reg- ulatory mechanisms that act to respond to various signaling cues. These cues are coordinated in a developmental, species-, and tissue-specific manner, with an additional time/circadian-dependent level of regulation. This brief review will highlight some of the signal transduction cascades and transcription factors that have been shown to modulate CYP17 gene expression in the adrenal cortex. Keywords: CYP17, adrenocorticotropin, angiotensin II, cAMP, steroid hydroxylase, steroidogenic factor-1, PKA 1. Overview sponse, and is produced in the zona fasciculata. This re- view will focus on the transcriptional regulation of Steroid hormones exert control of diverse physiologi- CYP17. CYP17 is localized in the endoplasmic reticulum cal processes by serving as ligands for intracellular and and catalyzes both the 17-hydroxylation of pregnenolone plasma membrane receptors.
    [Show full text]
  • Frank B. Furnari
    CURRIULUM VITAE Frank B. Furnari Work Address: Ludwig Institute for Cancer Research & University of California, San Diego CMM-E, Room 3053 9500 Gilman Drive La Jolla, CA 92093-0660 Phone: (858) 534-7809 (lab), -7819 (office) Fax: (858) 534-7750 e-mail: [email protected] Date and Place of Birth: May 30, 1964, Queens, New York Education: B.A. awarded: May, 1985 in Biology, Hofstra University, Hempstead, New York Ph.D. awarded: January, 1993 in Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina Professional History: 1987-1993: Graduate student, Microbiology and Immunology, University of North Carolina: Chapel Hill, NC. 2/93-7/00: Postdoctoral fellow, Ludwig Institute for Cancer Research & University of California, San Diego; La Jolla, CA. 8/00-4/07: Assistant Investigator and Head of the Section of Human Carcinogenesis: Ludwig Institute for Cancer Research-San Diego 4/07-11/11: Associate Investigator and Head of the Section of Human Carcinogenesis: Ludwig Institute for Cancer Research-San Diego 11/11-6/15: Senior Investigator and Head of the Section of Human Carcinogenesis: Ludwig Institute for Cancer Research-San Diego 6/15-12/15: Senior Investigator and Head Laboratory of Tumor Biology: Ludwig Institute for Cancer Research-San Diego 1/16-present: Member and Head Laboratory of Tumor Biology: Ludwig Institute for Cancer Research-San Diego 7/01-6/07: Assistant Adjunct Professor, UCSD Department of Medicine 7/07-10/11: Associate Adjunct Professor, UCSD Department of Medicine 3/01-9/05: Associate Member,
    [Show full text]
  • Personal Information Professional Summary
    Personal Information Full Name: L. Ashley Cowart, Ph.D. Title: Professor, Director, Lipidomics Core Facility, Research Health Scientist Business Name: Virginia Commonwealth University Business Address: 1101 E. Marshall St., Sanger Hall 2-016A, Richmond, VA 23219 Phone: 804-827--791 Email: [email protected] Languages Spoken: English Professional Summary Primary Departmental Specialization Area/Field Lipid metabolism, signaling, and biology in the context of diabetes and related metabolic disorders Areas of Expertise and Interest lipid signaling sphingolipids ceramide sphingosine-1-phosphate enzyme kinetics membranes protein structure diabetes obesity non-alcoholic fatty liver disease diabetic cardiomyopathy adipose tissue adipogenesis insulin resistance obesity lipidomics Cowart, Lauren A. 1 of 21 lipid metabolism Education Post Graduate Postdoctoral Fellowship, Medical University of South Carolina, Charleston, SC, Biochemistry and Molecular Biology 08/2001 - 05/2005 Graduate Vanderbilt University, Nashville, TN, NOVEL PATHWAYS OF CYTOCHROME P450- MEDIATED ARACHIDONIC ACID BIOACTIVATION, Jorge H. Capdevila. 08/1995 - 12/2001 Undergraduate Furman University, Greenville, SC, Biology, B.S., 1995, 08/1991 - 05/1995 Academic Appointment History Professor, tenure track, Virginia Commonwealth University College of Medicine 11/2017 - Present Associate Professor with tenure, Medical University of South Carolina College of Medicine 01/2017 - 10/2017 Associate Professor, tenure track, Medical University of South Carolina College of Medicine 07/2014 - 12/2016 Assistant Professor, tenure track, Medical University of South Carolina College of Medicine 06/2009 - 06/2014 Assistant Professor, research track, Medical University of South Carolina College of Medicine 07/2005 - 05/2009 Employment History Research Health Scientist, McGuire Veterans Affairs Medical Center 11/2017 - Present Director, Lipidomics Shared Resource Facility, Virginia Commonwealth University College of Medicine 02/2018 (in progress) Cowart, Lauren A.
    [Show full text]
  • Regulation of Ceramide and Its Metabolites
    REGULATION OF CERAMIDE AND ITS METABOLITES: BIOSYNTHESIS & IN SITU SPHINGOLIPID ANALYSIS A Dissertation Presented to The Academic Faculty by Ying Liu In Partial Fulfillment of the Requirements for the Degree PH.D in the School of Biology Georgia Institute of Technology May/2010 REGULATION OF CERAMIDE AND ITS METABOLITES: BIOSYNTHESIS & IN SITU SPHINGOLIPID ANALYSIS Approved by Dr. Alfred Merrill, Advisor Dr. Julian Kubanek School of Biology School of Biology Georgia Institute of Technology Georgia Institute of Technology Dr. Marion Sewer Dr. Harish Radhakrishna Skaggs School of Pharmacy & Strategic Research Department Pharmaceutical Sciences The Coca-Cola Company University of California Dr. Paula M. Vertino Winship Cancer Institute Emory University Date Approved: Dec 14 th , 2010 ii To my familiy iii ACKNOWLEDGEMENTS First of all, I would like to thank Dr. Alfred Merrill, my advisor, for giving me the opportunity to join his research group and explore the exciting research world of sphingolipids. Without his encouragement, support and guidance through my whole graduate studies here at Georgia Tech, I could not have achieved the goal. I am so grateful to my thesis committee members: Dr. Julia Kubanek, Dr. Marion Sewer, Dr. Paula M. Vertino, Dr. Harish Radhakrishna, for their time and good advices. I want to express my appreciation to Dr. Yanfeng Chen and Samuel Kelly, for their valuable guidance and insightful comments in the field of mass spectrometry. Special thanks to Dr. Cameron Sullards, David Bostwick in mass spectrometry facilities. I would like to thank Dr. Martina Leipelt and Dr. Qiong Peng for their generous help in molecular biology. I am grateful to Dr.
    [Show full text]
  • [Thesis Title Goes Here]
    APPLICATION OF BIOINFORMATICS IN STUDIES OF SPHINGOLIPID BIOSYNTHESIS A Dessertation Presented to The Academic Faculty by Amin Altaf Momin In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Biology, College of sciences Georgia Institute of Technology August 2010 APPLICATION OF BIOINFORMATICS IN STUDIES OF SPHINGOLIPID BIOSYNTHESIS Approved by: Dr. Alfred H Merrill Jr, Advisor Dr. Stephen C Harvey School of Biology School of Biology Georgia Institute of Technology Georgia Institute of Technology Dr Cameron Sullards Dr. Marion B. Sewer School of Chemistry and Biochemistry School of Pharmacy and Georgia Institute of Technology Pharmaceutical Sciences University of California, San Diego Dr I King Jordan School of Biology Georgia Institute of Technology Date Approved: 05/14/2010 This thesis is dedicated to my parents iii ACKNOWLEDGEMENTS I wish to thanks my Advisor Dr Alfred Merrill for all his kind advice and support during my graduate study. His encouragement and insight has been instrumental in shaping studies and overcoming challenging during my project. I would also like to think my committee members Dr Marion Sewer, Dr King Jordan, Dr Cameron Sullards, Dr Steve Harvey and a previous member Dr John Cairney for their valuable advice and constructive feedback during my dissertation. All this work wouldn’t be possible without the support of all my co-workers in the Merrill lab including Samuel Kelly, Chris Haynes, Hyejung Park, Kacee Sim, Kristin Jones, Jeremy Allegood, Jia Wei, Rebecca Shaner, Ying Liu, Martina Liepelt and Brent Portz. I am especially thankful to Elaine Wang for her advice and support during all these years in graduate school.
    [Show full text]
  • Modulating the Functional Contributions of C-Myc to the Human Endothelial Cell Cyclic Strain Response
    MODULATING THE FUNCTIONAL CONTRIBUTIONS OF C-MYC TO THE HUMAN ENDOTHELIAL CELL CYCLIC STRAIN RESPONSE A Dissertation Presented to The Academic Faculty By Nicole Elizabeth Hurley In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy in Bioengineering Georgia Institute of Technology December, 2007 MODULATING THE FUNCTIONAL CONTRIBUTIONS OF C-MYC TO THE HUMAN ENDOTHELIAL CELL CYCLIC STRAIN RESPONSE Approved by: Dr. Larry McIntire, Advisor Dr. Todd McDevitt Wallace H. Coulter Department of Wallace H. Coulter Department of Biomedical Engineering Biomedical Engineering Georgia Institute of Technology and Georgia Institute of Technology and Emory University School of Medicine Emory University School of Medicine Dr. Suzanne Eskin Dr. Marion Sewer Wallace H. Coulter Department of School of Biology Biomedical Engineering Georgia Institute of Technology Georgia Institute of Technology and Emory University School of Medicine Dr. Raymond Vito The George W. Woodruff School of Mechanical Engineering Georgia Institute of Technology Date approved: October 30, 2007 To my family, with love, for always encouraging me, believing in me, and for reminding me what really matters. iii ACKNOWLEDGEMENTS I would like to express my deep gratitude to the many people who have given me invaluable support for this work and my graduate studies. I would like to thank my advisors at Georgia Tech, Dr. Larry V. McIntire and Dr. Suzanne G. Eskin, for their continued knowledge, guidance, support and patient direction. Thank you to Dr. Zorina Galis for giving me support, generosity and an educating spirit during my work at Emory University. In addition, I appreciate the valuable input and guidance of the rest of my thesis committee, Dr.
    [Show full text]
  • American Society for Biochemistry and Molecular Biology
    Vol. 12 No. 8 September 2013 American Society for Biochemistry and Molecular Biology contents SEPTEMBER 2013 In our cover story, science writer Rajendrani news Mukhopadhyay talks to frequent-flyers who are 2 President’s Message maintaining research Solving the insoluble (and watching them dance) programs in different parts of the world. 14 5 Member Update An open letter to our readers who have something to say 6 News from the Hill but need a place (and maybe even permission) to say it Will this time be any different? 7 Herbert Tabor Young Dear Reader, Investigator awards This is your magazine. Seriously, it is. You support it when you renew your ASBMB dues, share its contents with 8 Retrospective your friends and colleagues, crack it open on the train and even when you use it as a coaster for your coffee mug. Christian de Duve (1917 – 2013) In the second to last installment of our It’s yours. series, H. Jane Dyson writes about her essay winding career path. 12 Over the past two years, we’ve worked hard to get more of *you* in these pages. We’ve asked for your science- 10 Jack of a few trades, inspired poems (thanks for humoring me), your unique perspectives (keep ’em coming) and, most recently, your Master of Science inspiring stories of failure and triumph (the “Derailed but Undeterred” series). Your contributions have trans- formed this magazine into one with greater depth, unique storytelling and diversity of ideas. features For our next essay series, to be published in 2014, we want your letters.
    [Show full text]
  • Androgen-Independent Prostate Cancer Cells Acquire the Complete Steroidogenic Potential of Synthesizing Testosterone from Cholesterol
    University of Nebraska Medical Center DigitalCommons@UNMC Journal Articles: Biochemistry & Molecular Biology Biochemistry & Molecular Biology 11-25-2008 Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Paulette R. Dillard Clark Atlanta University Ming-Fong Lin University of Nebraska Medical Center, [email protected] Shafiq A. Khan Clark Atlanta University Follow this and additional works at: https://digitalcommons.unmc.edu/com_bio_articles Part of the Medical Biochemistry Commons, and the Medical Molecular Biology Commons Recommended Citation Dillard, Paulette R.; Lin, Ming-Fong; and Khan, Shafiq A., Andr" ogen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol." (2008). Journal Articles: Biochemistry & Molecular Biology. 35. https://digitalcommons.unmc.edu/com_bio_articles/35 This Article is brought to you for free and open access by the Biochemistry & Molecular Biology at DigitalCommons@UNMC. It has been accepted for inclusion in Journal Articles: Biochemistry & Molecular Biology by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. NIH Public Access Author Manuscript Mol Cell Endocrinol . Author manuscript; available in PMC 2010 January 5. NIH-PA Author NIH-PA ManuscriptPublishedAuthor NIH-PA Manuscript in final editedAuthor NIH-PA Manu form as: Mol Cell Endocrinol . 2008 November 25; 295(1-2): 115–120. doi:10.1016/j.mce.2008.08.013.
    [Show full text]